{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:19:38Z","timestamp":1783675178295,"version":"3.55.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the \u201cThree 100s\u201d Program for Overseas Training of Medical Science and Technology Talents in Henan Academy of Medical Science","award":["HNMOT2024025"],"award-info":[{"award-number":["HNMOT2024025"]}]},{"name":"Henan Province Medical Science Technology Research Program Joint Construction Project","award":["LHGJ20240359"],"award-info":[{"award-number":["LHGJ20240359"]}]},{"name":"Tianjian Laboratory of Advanced Biomedical Sciences."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12015-026-11161-1","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:16:00Z","timestamp":1779862560000},"page":"2691-2703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amniotic Fluid Stem Cells in Birth Defects: Integrated Roles in Disease Modeling, Prenatal Diagnosis, and Therapy"],"prefix":"10.1007","volume":"22","author":[{"given":"Yuanhang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"11161_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/children8100862","author":"RP Verma","year":"2021","unstructured":"Verma, R. P. (2021). Evaluation and risk assessment of congenital anomalies in neonates. Children. https:\/\/doi.org\/10.3390\/children8100862","journal-title":"Children"},{"key":"11161_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/s096553951500008x","author":"KN Benn Pb","year":"2014","unstructured":"Benn Pb, K. N., Campbell Am, W. A., & S., A. A. (2014). Genetic sonogram: Components and role in the era of prenatal screening. Fetal and Maternal Medicine Review. https:\/\/doi.org\/10.1017\/s096553951500008x","journal-title":"Fetal and Maternal Medicine Review"},{"issue":"2","key":"11161_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41591-023-02774-x","volume":"30","author":"Z Jinglan","year":"2024","unstructured":"Jinglan, Z., Yanting, W., Songchang, C., et al. (2024). Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies. Nature Medicine, 30(2), 470\u2013479.","journal-title":"Nature Medicine"},{"issue":"2","key":"11161_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.18773\/austprescr.2025.019","volume":"48","author":"A Poulton","year":"2025","unstructured":"Poulton, A., & Hui, L. (2025). Noninvasive prenatal testing: An overview. Aust Prescr, 48(2), 47\u201353.","journal-title":"Aust Prescr"},{"issue":"1","key":"11161_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ped4.12419","volume":"8","author":"Y Liu","year":"2024","unstructured":"Liu, Y., & Qian, S. (2024). Current situation and prospect for the diagnosis and treatment of pediatric critical rare diseases in China. Pediatr Investig, 8(1), 66\u201371.","journal-title":"Pediatr Investig"},{"issue":"1","key":"11161_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson, A., & McDonald, C. (2015). Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell, 17(1), 11\u201322.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"11161_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/embor.2010.47","volume":"11","author":"A Banito","year":"2010","unstructured":"Banito, A., & Gil, J. (2010). Induced pluripotent stem cells and senescence: Learning the biology to improve the technology. Embo Reports, 11(5), 353\u2013359.","journal-title":"Embo Reports"},{"issue":"1680","key":"11161_CR8","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0367","volume":"370","author":"M Ohnuki","year":"2015","unstructured":"Ohnuki, M., & Takahashi, K. (2015). Present and future challenges of induced pluripotent stem cells. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 370(1680), Article 20140367.","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"3","key":"11161_CR9","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.18295\/squmj.2018.18.03.002","volume":"18","author":"R Berebichez-Fridman","year":"2018","unstructured":"Berebichez-Fridman, R., & Montero-Olvera, P. R. (2018). Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J, 18(3), e264\u2013e277.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"11161_CR10","doi-asserted-by":"crossref","unstructured":"Rodrigues, M., Blattner, C., & Stuppia, L. (2019). Amniotic Fluid Cells, Stem Cells, and p53: Can We Stereotype p53 Functions. International Journal Of Molecular Sciences. 20(9).","DOI":"10.3390\/ijms20092236"},{"key":"11161_CR11","doi-asserted-by":"crossref","unstructured":"SP LOUKOGEORGAKIS PM, P DE C (2013). Recent developments in therapies with stem cells from amniotic fluid and placenta. Fetal and Maternal Medicine Review.","DOI":"10.1017\/S0965539513000107"},{"issue":"3","key":"11161_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ajog.2018.05.035","volume":"219","author":"CD Dolin","year":"2018","unstructured":"Dolin, C. D., Chan, M. K., Basch, R. S., & Young, B. K. (2018). Human term amniotic fluid: A novel source of stem cells for regenerative medicine. American Journal Of Obstetrics And Gynecology, 219(3), 308\u2013309.","journal-title":"American Journal Of Obstetrics And Gynecology"},{"key":"11161_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010050","author":"P Sabbatini","year":"2025","unstructured":"Sabbatini, P., Cipriani, S., & Biagini, A. (2025). Potassium current signature of neuronal\/glial progenitors in amniotic fluid stem cells. Cells. https:\/\/doi.org\/10.3390\/cells14010050","journal-title":"Cells"},{"key":"11161_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073713","author":"A Costa","year":"2021","unstructured":"Costa, A., Ceresa, D., & De Palma, A. (2021). Comprehensive profiling of secretome formulations from fetal- and perinatal human amniotic fluid stem cells. International Journal Of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22073713","journal-title":"International Journal Of Molecular Sciences"},{"issue":"1","key":"11161_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13287-017-0582-6","volume":"8","author":"R Moraghebi","year":"2017","unstructured":"Moraghebi, R., Kirkeby, A., Chaves, P., et al. (2017). Term amniotic fluid: An unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications. Stem Cell Research & Therapy, 8(1), 190.","journal-title":"Stem Cell Research & Therapy"},{"key":"11161_CR16","doi-asserted-by":"crossref","unstructured":"Lennon, M. L., Frieman, A., Salazar, A. K., Kogut, I., Bilousova, G., & Jacot, J. G. (2025). Amniotic fluid collected from vaginal birth as a source of stem cells for clinical applications and disease modeling. Stem Cells Transl Med. 14(7).","DOI":"10.1093\/stcltm\/szaf017"},{"issue":"11","key":"11161_CR17","first-page":"RA253","volume":"8","author":"A Prusa","year":"2002","unstructured":"Prusa, A., & Hengstschlager, M. (2002). Amniotic fluid cells and human stem cell research: A new connection. Medical Science Monitor, 8(11), RA253\u2013RA257.","journal-title":"Medical Science Monitor"},{"issue":"9","key":"11161_CR18","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/j.1582-4934.2010.01180.x","volume":"15","author":"MG Roubelakis","year":"2011","unstructured":"Roubelakis, M. G., Bitsika, V., Zagoura, D., et al. (2011). In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. Journal Of Cellular And Molecular Medicine, 15(9), 1896\u20131913.","journal-title":"Journal Of Cellular And Molecular Medicine"},{"key":"11161_CR19","doi-asserted-by":"crossref","unstructured":"de la Torre, P., & Flores, A. I. (2020). Current Status and Future Prospects of Perinatal Stem Cells. Genes (Basel). 12(1).","DOI":"10.3390\/genes12010006"},{"issue":"2","key":"11161_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","volume":"26","author":"O Parolini","year":"2008","unstructured":"Parolini, O., Alviano, F., & Bagnara, G. P. (2008). Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells, 26(2), 300\u201311.","journal-title":"Stem Cells"},{"issue":"7","key":"11161_CR21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/deg279","volume":"18","author":"AR Prusa","year":"2003","unstructured":"Prusa, A. R., Marton, E., Rosner, M., Bernaschek, G., & Hengstschl\u00e4ger, M. (2003). Oct-4-expressing cells in human amniotic fluid: A new source for stem cell research. Human Reproduction, 18(7), 1489\u20131493.","journal-title":"Human Reproduction"},{"issue":"7","key":"11161_CR22","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/stem.2553","volume":"35","author":"SP Loukogeorgakis","year":"2017","unstructured":"Loukogeorgakis, S. P., De Coppi, P., & Concise Review (2017). Amniotic Fluid Stem Cells: The Known, the Unknown, and Potential Regenerative Medicine Applications. Stem Cells, 35(7), 1663\u20131673.","journal-title":"Stem Cells"},{"key":"11161_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2012.05.032","volume":"1466","author":"S Park","year":"2012","unstructured":"Park, S., Kim, E., Koh, S., et al. (2012). Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson\u2019s disease model rats and alleviation of asymmetric rotational behavior. Brain Research, 1466, 158\u2013166.","journal-title":"Brain Research"},{"issue":"6","key":"11161_CR24","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/humrep\/deh279","volume":"19","author":"M Tsai","year":"2004","unstructured":"Tsai, M., Lee, J., Chang, Y., & Hwang, S. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction, 19(6), 1450\u20131456.","journal-title":"Human Reproduction"},{"issue":"3","key":"11161_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1089\/scd.2012.0267","volume":"22","author":"D Moschidou","year":"2013","unstructured":"Moschidou, D., Mukherjee, S., Blundell, M. P., et al. (2013). Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells And Development, 22(3), 444\u2013458.","journal-title":"Stem Cells And Development"},{"issue":"6","key":"11161_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1089\/scd.2007.0036","volume":"16","author":"MG Roubelakis","year":"2007","unstructured":"Roubelakis, M. G., Pappa, K. I., Bitsika, V., et al. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: Comparison to bone marrow mesenchymal stem cells. Stem Cells And Development, 16(6), 931\u2013952.","journal-title":"Stem Cells And Development"},{"issue":"3","key":"11161_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1095\/biolreprod.105.046029","volume":"74","author":"T Ming-Song","year":"2006","unstructured":"Ming-Song, T., Shiaw-Min, H., Yieh-Loong, T., Fu-Chou, C., Jia-Ling, L., & Yu-Jen, C. (2006). Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biology of Reproduction, 74(3), 545\u2013551.","journal-title":"Biology of Reproduction"},{"key":"11161_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/319238","volume":"2015","author":"J Savickiene","year":"2015","unstructured":"Savickiene, J., Treigyte, G., & Baronaite, S. (2015). Human amniotic fluid mesenchymal stem cells from second- and third-trimester amniocentesis: Differentiation potential, molecular signature, and proteome analysis. Stem Cells International, 2015, Article 319238.","journal-title":"Stem Cells International"},{"issue":"10","key":"11161_CR29","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/mt.2012.117","volume":"20","author":"D Moschidou","year":"2012","unstructured":"Moschidou, D., Mukherjee, S., Blundell, M. P., et al. (2012). Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Molecular Therapy, 20(10), 1953\u20131967.","journal-title":"Molecular Therapy"},{"issue":"3","key":"11161_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00418-020-01940-3","volume":"155","author":"L Centurione","year":"2021","unstructured":"Centurione, L., Centurione, M. A., Antonucci, I., et al. (2021). Human amniotic fluid stem cells are able to form embryoid body-like aggregates which performs specific functions: Morphological evidences. Histochemistry And Cell Biology, 155(3), 381\u2013390.","journal-title":"Histochemistry And Cell Biology"},{"issue":"1","key":"11161_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nbt1274","volume":"25","author":"P De Coppi","year":"2007","unstructured":"De Coppi, P., Bartsch, G., Siddiqui, M. M., et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 25(1), 100\u2013106.","journal-title":"Nature Biotechnology"},{"issue":"2","key":"11161_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.32607\/20758251-2009-1-2-98-103","volume":"1","author":"DA Davydova","year":"2009","unstructured":"Davydova, D. A., Vorotelyak, E. A., Smirnova, Y. A., et al. (2009). Cell phenotypes in human amniotic fluid. Acta Naturae, 1(2), 98\u2013103.","journal-title":"Acta Naturae"},{"issue":"3","key":"11161_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/org.22426","volume":"8","author":"M Cananzi","year":"2012","unstructured":"Cananzi, M., & De Coppi, P. (2012). CD117(+) amniotic fluid stem cells: State of the art and future perspectives. Organogenesis, 8(3), 77\u201388.","journal-title":"Organogenesis"},{"issue":"1","key":"11161_CR34","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1038\/s41598-019-44572-x","volume":"9","author":"F Vlahova","year":"2019","unstructured":"Vlahova, F., Hawkins, K. E., Ranzoni, A. M., et al. (2019). Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A. Scientific Reports, 9(1), 8126.","journal-title":"Scientific Reports"},{"issue":"3","key":"11161_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41591-024-02807-z","volume":"30","author":"GMF Maria","year":"2024","unstructured":"Maria, G. M. F., Giuseppe, C., Arran, B. M., et al. (2024). Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids. Nature Medicine, 30(3), 875\u2013887.","journal-title":"Nature Medicine"},{"issue":"2","key":"11161_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s13577-023-01008-z","volume":"37","author":"N Liu","year":"2024","unstructured":"Liu, N., Cheng, Y., Wang, D., et al. (2024). Tissue-specific populations from amniotic fluid-derived mesenchymal stem cells manifest variant in vitro and in vivo properties. Human Cell, 37(2), 408\u2013419.","journal-title":"Human Cell"},{"issue":"9","key":"11161_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11626-020-00511-z","volume":"56","author":"J Huang","year":"2020","unstructured":"Huang, J., Ma, W., Wei, X., & Yuan, Z. (2020). Amniotic fluid mesenchymal stromal cells from early stages of embryonic development have higher self-renewal potential. In Vitro Cellular And Developmental Biology. Animal, 56(9), 701\u2013714.","journal-title":"In Vitro Cellular And Developmental Biology. Animal"},{"issue":"5","key":"11161_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s12015-014-9525-0","volume":"10","author":"B Rossi","year":"2014","unstructured":"Rossi, B., Merlo, B., Colleoni, S., et al. (2014). Isolation and in vitro characterization of bovine amniotic fluid derived stem cells at different trimesters of pregnancy. Stem Cell Rev Rep, 10(5), 712\u2013724.","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"11161_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/bio.2019.0103","volume":"18","author":"B Borzou","year":"2020","unstructured":"Borzou, B., Mehrabani, D., Zare, S., Zamani-Pereshkaft, M., & Acker, J. P. (2020). The Effect of Age and Type of Media on Growth Kinetics of Human Amniotic Fluid Stem Cells. Biopreservation And Biobanking, 18(5), 389\u2013394.","journal-title":"Biopreservation And Biobanking"},{"issue":"3","key":"11161_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cbin.11099","volume":"43","author":"M Gasi\u016bnien\u0117","year":"2019","unstructured":"Gasi\u016bnien\u0117, M., Zentelyt\u0117, A., Treigyt\u0117, G., et al. (2019). Epigenetic alterations in amniotic fluid mesenchymal stem cells derived from normal and fetus-affected gestations: A focus on myogenic and neural differentiations. Cell Biology International, 43(3), 299\u2013312.","journal-title":"Cell Biology International"},{"issue":"2","key":"11161_CR41","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jcb.29416","volume":"121","author":"A Zentelyt\u0117","year":"2020","unstructured":"Zentelyt\u0117, A., Gasi\u016bnien\u0117, M., Treigyt\u0117, G., et al. (2020). Epigenetic regulation of amniotic fluid mesenchymal stem cell differentiation to the mesodermal lineages at normal and fetus-diseased gestation. Journal Of Cellular Biochemistry, 121(2), 1811\u20131822.","journal-title":"Journal Of Cellular Biochemistry"},{"key":"11161_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.700634","volume":"9","author":"G Valiulien\u0117","year":"2021","unstructured":"Valiulien\u0117, G., Zentelyt\u0117, A., Ber\u017eanskyt\u0117, E., & Navakauskien\u0117, R. (2021). Metabolic profile and neurogenic potential of human amniotic fluid stem cells from normal vs. fetus-affected gestations. Frontiers in Cell and Developmental Biology, 9, Article 700634.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"11161_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114048","volume":"439","author":"L Pontiggia","year":"2024","unstructured":"Pontiggia, L., Michalak-Micka, K., H\u00fcrlimann, N., et al. (2024). Raman spectroscopy analysis of human amniotic fluid cells from fetuses with myelomeningocele. Experimental Cell Research, 439(1), Article 114048.","journal-title":"Experimental Cell Research"},{"key":"11161_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121577","author":"A Dasargyri","year":"2023","unstructured":"Dasargyri, A., Rodr\u00edguez, D. G., Rehrauer, H., Reichmann, E., Biedermann, T., & Moehrlen, U. (2023). scRNA-Seq of cultured human amniotic fluid from fetuses with spina bifida reveals the origin and heterogeneity of the cellular content. Cells. https:\/\/doi.org\/10.3390\/cells12121577","journal-title":"Cells"},{"key":"11161_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biology12040552","author":"M Jain","year":"2023","unstructured":"Jain, M., Singh, N., & Fatima, R. (2023). Amniotic fluid mesenchymal stromal cells derived from fetuses with isolated cardiac defects exhibit decreased proliferation and cardiomyogenic potential. Biology. https:\/\/doi.org\/10.3390\/biology12040552","journal-title":"Biology"},{"issue":"1","key":"11161_CR46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s13287-025-04654-2","volume":"16","author":"T Phermthai","year":"2025","unstructured":"Phermthai, T., Thongbopit, S., Wataganara, T., et al. (2025). Clinical-grade allogeneic amniotic fluid stem cell banking: Quality control for therapeutic applications and drug development. Stem Cell Research & Therapy, 16(1), 509.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11161_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-32738-9","volume":"16","author":"\u00c7 Mehmet","year":"2025","unstructured":"Mehmet, \u00c7., Tar\u0131k, Y. \u00d6., & G\u00f6khan, K. S. (2025). Clinical feasibility and cost efficiency of perinatal mesenchymal stem cell production under GMP conditions. Scientific Reports, 16(1), Article 2791.","journal-title":"Scientific Reports"},{"issue":"1","key":"11161_CR48","volume":"27","author":"\u00c7 Mehmet","year":"2025","unstructured":"Mehmet, \u00c7., Tar\u0131k, Y. \u00d6., & G\u00f6khan, K. S. (2025). Comprehensive evaluation of the clinical feasibility of using perinatal medical waste as a source for fetal mesenchymal stem cell banking under good manufacturing practice conditions. Cell and Tissue Banking, 27(1), Article 1.","journal-title":"Cell and Tissue Banking"},{"key":"11161_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1020986","volume":"10","author":"F Balsamo","year":"2022","unstructured":"Balsamo, F., Tian, Y., Pierro, A., & Li, B. (2022). Amniotic fluid stem cells: A novel treatment for necrotizing enterocolitis. Frontiers in Pediatrics, 10, Article 1020986.","journal-title":"Frontiers in Pediatrics"},{"key":"11161_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.placenta.2021.01.009","volume":"104","author":"Y Abe","year":"2021","unstructured":"Abe, Y., Ochiai, D., Sato, Y., et al. (2021). Amniotic fluid stem cells as a novel strategy for the treatment of fetal and neonatal neurological diseases. Placenta, 104, 247\u2013252.","journal-title":"Placenta"},{"key":"11161_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010102","author":"Y Fang","year":"2020","unstructured":"Fang, Y., Wang, S. P. H., Chang, H., Yang, P., Liu, P., & Liu, Y. (2020). Progress and challenges of amniotic fluid derived stem cells in therapy of ischemic heart disease. International Journal Of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22010102","journal-title":"International Journal Of Molecular Sciences"},{"key":"11161_CR52","doi-asserted-by":"crossref","unstructured":"Gatti, M., Beretti, F., Malenchini, M. (2025). Mesenchymal Stromal Cell-Derived Extracellular Vesicles as a Therapeutic Treatment for Osteosarcopenia: Crosstalk Among Neurons, Muscle, and Bone. International Journal Of Molecular Sciences. 26(16).","DOI":"10.3390\/ijms26167875"},{"key":"11161_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312502","author":"M Gatti","year":"2024","unstructured":"Gatti, M., Beretti, F., & Ravegnini, G. (2024). Evaluation of the anti-cancer potential of extracellular vesicles derived from human amniotic fluid stem cells: Focus on effective miRNAs in the treatment of melanoma progression. International Journal Of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms252312502","journal-title":"International Journal Of Molecular Sciences"},{"issue":"1","key":"11161_CR54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12967-024-05154-2","volume":"22","author":"I Atukorala","year":"2024","unstructured":"Atukorala, I., Hannan, N., & Hui, L. (2024). Immersed in a reservoir of potential: Amniotic fluid-derived extracellular vesicles. J Transl Med, 22(1), 348.","journal-title":"J Transl Med"},{"key":"11161_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells12192347","author":"E Russo","year":"2023","unstructured":"Russo, E., Alberti, G., & Corrao, S. (2023). The truth is out there: Biological features and clinical indications of extracellular vesicles from human perinatal stem cells. Cells. https:\/\/doi.org\/10.3390\/cells12192347","journal-title":"Cells"},{"issue":"9\u201310","key":"11161_CR56","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1177\/0963689719854342","volume":"28","author":"TT Sibov","year":"2019","unstructured":"Sibov, T. T., Pavon, L. F., Cabral, F. R., et al. (2019). Intravenous grafts of human amniotic fluid-derived stem cells reduce behavioral deficits in experimental ischemic stroke. Cell Transplantation, 28(9\u201310), 1306\u20131320.","journal-title":"Cell Transplantation"},{"issue":"10","key":"11161_CR57","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/WNR.0000000000001473","volume":"31","author":"H Zhou","year":"2020","unstructured":"Zhou, H., Fang, H., Luo, H., et al. (2020). Intravenous administration of human amniotic mesenchymal stem cells improves outcomes in rats with acute traumatic spinal cord injury. Neuroreport, 31(10), 730\u2013736.","journal-title":"Neuroreport"},{"key":"11161_CR58","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720909387","volume":"29","author":"C Liang","year":"2020","unstructured":"Liang, C., Shaw, S. S., Chou, H., Huang, Y., & Lee, T. (2020). Amniotic fluid stem cells improve rat bladder dysfunction after pelvic nerve transection. Cell Transplantation, 29, Article 963689720909387.","journal-title":"Cell Transplantation"},{"issue":"1","key":"11161_CR59","first-page":"723","volume":"18","author":"L Ran","year":"2018","unstructured":"Ran, L., Zeng, Y., Wang, S., et al. (2018). Effect of co\u2013culture with amniotic epithelial cells on the biological characteristics of amniotic mesenchymal stem cells. Molecular Medicine Reports, 18(1), 723\u2013732.","journal-title":"Molecular Medicine Reports"},{"issue":"4","key":"11161_CR60","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s11033-021-07069-3","volume":"49","author":"F Sadri","year":"2022","unstructured":"Sadri, F., Rezaei, Z., & Fereidouni, M. (2022). The significance of the SDF-1\/CXCR4 signaling pathway in the normal development. Molecular Biology Reports, 49(4), 3307\u20133320.","journal-title":"Molecular Biology Reports"},{"key":"11161_CR61","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jconrel.2024.05.009","volume":"370","author":"J Zheng","year":"2024","unstructured":"Zheng, J., Park, K., Jang, J., et al. (2024). Utilizing stem cell-secreted molecules as a versatile toolbox for skin regenerative medicine. Journal Of Controlled Release : Official Journal Of The Controlled Release Society, 370, 583\u2013599.","journal-title":"Journal Of Controlled Release : Official Journal Of The Controlled Release Society"},{"issue":"2","key":"11161_CR62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/biof.1407","volume":"44","author":"F Beretti","year":"2018","unstructured":"Beretti, F., Zavatti, M., Casciaro, F., et al. (2018). Amniotic fluid stem cell exosomes: Therapeutic perspective. Biofactors (Oxford, England), 44(2), 158\u2013167.","journal-title":"Biofactors (Oxford, England)"},{"key":"11161_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.705676","volume":"9","author":"J Johnson","year":"2021","unstructured":"Johnson, J., Shojaee, M., Crow, J. M., & Khanabdali, R. (2021). From mesenchymal stromal cells to engineered extracellular vesicles: A new therapeutic paradigm. Frontiers in Cell and Developmental Biology, 9, Article 705676.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"11161_CR64","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00441-025-03984-0","volume":"401","author":"T Phermthai","year":"2025","unstructured":"Phermthai, T., Chuaynarong, P., Wichitwiengrat, S., et al. (2025). Proteomic analysis of secreted proteins derived from amniotic fluid stem cells. Cell And Tissue Research, 401(3), 275\u2013286.","journal-title":"Cell And Tissue Research"},{"issue":"1","key":"11161_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41598-020-80326-w","volume":"11","author":"M Kukumberg","year":"2021","unstructured":"Kukumberg, M., Phermthai, T., Wichitwiengrat, S., et al. (2021). Hypoxia-induced amniotic fluid stem cell secretome augments cardiomyocyte proliferation and enhances cardioprotective effects under hypoxic-ischemic conditions. Scientific Reports, 11(1), 163.","journal-title":"Scientific Reports"},{"key":"11161_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103241","volume":"75","author":"G Senesi","year":"2024","unstructured":"Senesi, G., Guerricchio, L., Ghelardoni, M., et al. (2024). Extracellular vesicles from II trimester human amniotic fluid as paracrine conveyors counteracting oxidative stress. Redox Biology, 75, Article 103241.","journal-title":"Redox Biology"},{"issue":"1","key":"11161_CR67","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v18.i1.113614","volume":"18","author":"C Liang","year":"2026","unstructured":"Liang, C., Lin, Y., Liang, C., Ro, A., Huang, Y., & Shaw, S. W. (2026). Extracellular vesicles derived from human amniotic fluid stem cells improve bladder dysfunction in rat model of diabetic atherosclerosis. World Journal of Stem Cells, 18(1), Article 113614.","journal-title":"World Journal of Stem Cells"},{"key":"11161_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijcard.2019.04.011","volume":"287","author":"C Balbi","year":"2019","unstructured":"Balbi, C., Lodder, K., Costa, A., et al. (2019). Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome. International Journal of Cardiology, 287, 87\u201395.","journal-title":"International Journal of Cardiology"},{"key":"11161_CR69","doi-asserted-by":"crossref","unstructured":"Fang, Y., Wang, S. P. H., Gao, Z. (2020). Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege. International Journal Of Molecular Sciences 21(7).","DOI":"10.3390\/ijms21072359"},{"issue":"2","key":"11161_CR70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/gutjnl-2012-303735","volume":"63","author":"A Zani","year":"2014","unstructured":"Zani, A., Cananzi, M., Fascetti-Leon, F., et al. (2014). Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut, 63(2), 300\u2013309.","journal-title":"Gut"},{"issue":"11","key":"11161_CR71","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1089\/scd.2010.0424","volume":"20","author":"S Bollini","year":"2011","unstructured":"Bollini, S., Cheung, K. K., Riegler, J., et al. (2011). Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells And Development, 20(11), 1985\u20131994.","journal-title":"Stem Cells And Development"},{"issue":"3","key":"11161_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/dna.2024.0254","volume":"44","author":"Y Jiang","year":"2025","unstructured":"Jiang, Y., Li, Y., Duan, L., & Jiang, B. (2025). Amniotic Fluid-Derived Stem Cells: An Overlooked Source of Stem Cells for Translational Research. Dna And Cell Biology, 44(3), 144\u2013152.","journal-title":"Dna And Cell Biology"},{"issue":"4","key":"11161_CR73","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/1574888X14666190222201749","volume":"14","author":"CR Harrell","year":"2019","unstructured":"Harrell, C. R., Gazdic, M., Fellabaum, C., et al. (2019). Therapeutic potential of amniotic fluid derived mesenchymal stem cells based on their differentiation capacity and immunomodulatory properties. Current Stem Cell Research & Therapy, 14(4), 327\u2013336.","journal-title":"Current Stem Cell Research & Therapy"},{"issue":"2","key":"11161_CR74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/cell.2009.0077","volume":"12","author":"E Galende","year":"2010","unstructured":"Galende, E., Karakikes, I., Edelmann, L., et al. (2010). Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram, 12(2), 117\u2013125.","journal-title":"Cell Reprogram"},{"issue":"12","key":"11161_CR75","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1089\/scd.2011.0715","volume":"21","author":"T Liu","year":"2012","unstructured":"Liu, T., Zou, G., Gao, Y., et al. (2012). High efficiency of reprogramming CD34\u207a cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4. Stem Cells And Development, 21(12), 2322\u20132332.","journal-title":"Stem Cells And Development"},{"issue":"1","key":"11161_CR76","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1262\/jrd.2012-109","volume":"59","author":"Q Li","year":"2013","unstructured":"Li, Q., Fan, Y., Sun, X., & Yu, Y. (2013). Generation of induced pluripotent stem cells from human amniotic fluid cells by reprogramming with two factors in feeder-free conditions. The Journal Of Reproduction And Development, 59(1), 72\u201377.","journal-title":"The Journal Of Reproduction And Development"},{"issue":"21","key":"11161_CR77","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1089\/scd.2014.0110","volume":"23","author":"G Jiang","year":"2014","unstructured":"Jiang, G., Bernardo, J. D., Maiden, M. M., et al. (2014). Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy. Stem Cells And Development, 23(21), 2613\u20132625.","journal-title":"Stem Cells And Development"},{"issue":"7313","key":"11161_CR78","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467(7313), 285\u2013290.","journal-title":"Nature"},{"issue":"6","key":"11161_CR79","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nprot.2010.74","volume":"5","author":"M Rosner","year":"2010","unstructured":"Rosner, M., Siegel, N., Fuchs, C., Slabina, N., Dolznig, H., & Hengstschl\u00e4ger, M. (2010). Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nature Protocols, 5(6), 1081\u20131095.","journal-title":"Nature Protocols"},{"key":"11161_CR80","doi-asserted-by":"publisher","first-page":"102315","DOI":"10.1016\/j.scr.2021.102315","volume":"53","author":"B Song","year":"2021","unstructured":"Song, B., Cheng, Y., Cao, D., et al. (2021). Generation of induced pluripotent stem cell line GZHMCi006-A from amniotic fluid-derived cells with deletion 14q syndrome. Stem Cell Res, 53, 102315.","journal-title":"Stem Cell Res"},{"key":"11161_CR81","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.scr.2021.102226","volume":"52","author":"C Yi","year":"2021","unstructured":"Yi, C., Dingya, C., Nengqing, L., et al. (2021). Generation of induced pluripotent stem cell GZHMCi005-A from amniotic fluid-derived cells with duplication of chromosome 8p. Stem Cell Res, 52, 102226.","journal-title":"Stem Cell Res"},{"issue":"2","key":"11161_CR82","first-page":"175","volume":"32","author":"Y Gong","year":"2015","unstructured":"Gong, Y., Li, Y., Song, Y., et al. (2015). [Establishment of induced pluripotent stem cell lines from human amniotic fluid cells with 1q21.1 microdeletion]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 32(2), 175\u2013179.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"11161_CR83","doi-asserted-by":"publisher","first-page":"102014","DOI":"10.1016\/j.scr.2020.102014","volume":"49","author":"P Long","year":"2020","unstructured":"Long, P., Wang, Z., Yang, H., et al. (2020). Generation of nine iPSC lines (HNMUi002-A, HNMUi003-A, HNMUi004-A, HNMUi005-A, HNMUi006-A, HNMUi007-A, HNMUi008-A, HNMUi009-A, HNMUi010-A) from three Chinese families with thalassemia. Stem Cell Res, 49, 102014.","journal-title":"Stem Cell Res"},{"key":"11161_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101712","volume":"43","author":"J Wang","year":"2020","unstructured":"Wang, J., Cui, Y., Xing, K., Luan, J., & Han, J. (2020). Generation and characterization of a human iPSC line derived from congenital clubfoot amniotic fluid cells. Stem Cell Research, 43, Article 101712.","journal-title":"Stem Cell Research"},{"key":"11161_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2025.103848","volume":"89","author":"P Manesha","year":"2025","unstructured":"Manesha, P., Cuneo Bettina, F., Congwu, C., Zhen, Z., Linnea, P., & Kunhua, S. (2025). Generation of human induced pluripotent stem cell lines from a fetus with congenital long QT syndrome and her healthy parents. Stem Cell Research, 89, Article 103848.","journal-title":"Stem Cell Research"},{"issue":"8","key":"11161_CR86","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1007\/s12035-025-04944-z","volume":"62","author":"JC Biancotti","year":"2025","unstructured":"Biancotti, J. C., Moore, H. E., Sescleifer, A. M., et al. (2025). Spinal Cord Organoids from Human Amniotic Fluid iPSC Recapitulate the Diversity of Cell Phenotypes During Fetal Neural Tube Morphogenesis. Molecular Neurobiology, 62(8), 10954\u201310969.","journal-title":"Molecular Neurobiology"},{"key":"11161_CR87","doi-asserted-by":"publisher","first-page":"103589","DOI":"10.1016\/j.scr.2024.103589","volume":"81","author":"M Boull\u00e9","year":"2024","unstructured":"Boull\u00e9, M., Leleu, A., Schacre, S., et al. (2024). Generation of IPi002-A\/B\/C human induced pluripotent stem cell lines from MARCH amniotic fluid cells. Stem Cell Res, 81, 103589.","journal-title":"Stem Cell Res"},{"issue":"2","key":"11161_CR88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5582\/irdr.218.01038","volume":"7","author":"K Xing","year":"2018","unstructured":"Xing, K., Cui, Y., Luan, J., Zhou, X., Shi, L., & Han, J. (2018). Establishment of a human trisomy 18 induced pluripotent stem cell line from amniotic fluid cells. Intractable Rare Dis Res, 7(2), 94\u201399.","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"11161_CR89","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.yexcr.2012.09.017","volume":"319","author":"H Lu","year":"2013","unstructured":"Lu, H., Yang, Y., Chen, S., et al. (2013). Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells. Experimental Cell Research, 319(4), 498\u2013505.","journal-title":"Experimental Cell Research"},{"issue":"5","key":"11161_CR90","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/cell.2013.0091","volume":"16","author":"C Pipino","year":"2014","unstructured":"Pipino, C., Mukherjee, S., David, A. L., et al. (2014). Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: Implications for disease modeling and cryobanking. Cell Reprogram, 16(5), 331\u2013344.","journal-title":"Cell Reprogram"},{"key":"11161_CR91","doi-asserted-by":"crossref","unstructured":"Cal\u00e0, G., D\u2019Ariano, G., Sun, K. Y. (2025). Derivation, expansion and cryopreservation of primary fetal organoids from second and third trimester human amniotic fluid cells. Nature Protocols.","DOI":"10.1038\/s41596-025-01227-8"},{"key":"11161_CR92","doi-asserted-by":"crossref","unstructured":"Tozer, L. (2024). Organoids grown from amniotic fluid could shed light on rare diseases. Nature.","DOI":"10.1038\/d41586-024-00656-x"},{"issue":"2","key":"11161_CR93","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/GCO.0000000000000610","volume":"32","author":"M Neofytou","year":"2020","unstructured":"Neofytou, M. (2020). Predicting fetoplacental mosaicism during cfDNA-based NIPT. Current Opinion In Obstetrics And Gynecology, 32(2), 152\u2013158.","journal-title":"Current Opinion In Obstetrics And Gynecology"},{"issue":"2","key":"11161_CR94","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ajmg.c.31505","volume":"172","author":"A Mardy","year":"2016","unstructured":"Mardy, A., & Wapner, R. J. (2016). Confined placental mosaicism and its impact on confirmation of NIPT results. Am J Med Genet C Semin Med Genet, 172(2), 118\u2013122.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"11161_CR95","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi, D. W., & Chiu, R. W. K. (2018). Sequencing of Circulating Cell-free DNA during Pregnancy. New England Journal Of Medicine, 379(5), 464\u2013473.","journal-title":"New England Journal Of Medicine"},{"issue":"6","key":"11161_CR96","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/clinchem\/hvac056","volume":"68","author":"M Rosner","year":"2022","unstructured":"Rosner, M., & Hengstschl\u00e4ger, M. (2022). Fetomaternal Microchimerism and Amniotic Fluid Stem Cells: The Current State of Knowledge. Clinical Chemistry, 68(6), 761\u2013764.","journal-title":"Clinical Chemistry"},{"issue":"13","key":"11161_CR97","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/pd.5186","volume":"37","author":"F Chen","year":"2017","unstructured":"Chen, F., Liu, P., Gu, Y., et al. (2017). Isolation and whole genome sequencing of fetal cells from maternal blood towards the ultimate non-invasive prenatal testing. Prenatal Diagnosis, 37(13), 1311\u20131321.","journal-title":"Prenatal Diagnosis"},{"issue":"6","key":"11161_CR98","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.tibtech.2018.11.001","volume":"37","author":"M Rezaei","year":"2019","unstructured":"Rezaei, M., Winter, M., Zander-Fox, D., et al. (2019). A reappraisal of circulating fetal cell noninvasive prenatal testing. Trends in Biotechnology, 37(6), 632\u2013644.","journal-title":"Trends in Biotechnology"},{"issue":"1","key":"11161_CR99","first-page":"1","volume":"8","author":"C Pin-Jung","year":"2019","unstructured":"Pin-Jung, C., Pai-Chi, T., Zhu, Y., et al. (2019). Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Curr Obstet Gynecol Rep, 8(1), 1\u20138.","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"4","key":"11161_CR100","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s12015-021-10228-5","volume":"18","author":"M Rosner","year":"2022","unstructured":"Rosner, M., Kolbe, T., Voronin, V., & Hengstschl\u00e4ger, M. (2022). Amniotic fluid stem cells and the cell source repertoire for non-invasive prenatal testing. Stem Cell Reviews and Reports, 18(4), 1366\u20131371.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"3","key":"11161_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2023.151728","volume":"47","author":"K Moskowitzova","year":"2023","unstructured":"Moskowitzova, K., & Fauza, D. O. (2023). Transamniotic stem cell therapy (TRASCET): An emerging minimally invasive strategy for intrauterine stem cell delivery. Seminars in Perinatology, 47(3), Article 151728.","journal-title":"Seminars in Perinatology"},{"key":"11161_CR102","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fphar.2014.00270","volume":"5","author":"DL Ramachandra","year":"2014","unstructured":"Ramachandra, D. L., Shaw, S. S. W., Shangaris, P., et al. (2014). In utero therapy for congenital disorders using amniotic fluid stem cells. Frontiers In Pharmacology, 5, 270.","journal-title":"Frontiers In Pharmacology"},{"issue":"1\u20132","key":"11161_CR103","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/pr.2017.228","volume":"83","author":"DO Fauza","year":"2018","unstructured":"Fauza, D. O. (2018). Transamniotic stem cell therapy: A novel strategy for the prenatal management of congenital anomalies. Pediatric Research, 83(1\u20132), 241\u2013248.","journal-title":"Pediatric Research"},{"issue":"6","key":"11161_CR104","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.siny.2014.09.006","volume":"19","author":"J Deprest","year":"2014","unstructured":"Deprest, J., Brady, P., Nicolaides, K., et al. (2014). Prenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial. Seminars in Fetal & Neonatal Medicine, 19(6), 338\u2013348.","journal-title":"Seminars in Fetal & Neonatal Medicine"},{"issue":"3","key":"11161_CR105","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/uog.6450","volume":"34","author":"JC Jani","year":"2009","unstructured":"Jani, J. C., Nicolaides, K. H., Gratac\u00f3s, E., et al. (2009). Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound in Obstetrics & Gynecology, 34(3), 304\u2013310.","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"11161_CR106","doi-asserted-by":"crossref","unstructured":"Antounians, L., Catania, V. D., Montalva, L. (2021). Fetal lung underdevelopment is rescued by administration of amniotic fluid stem cell extracellular vesicles in rodents. Sci Transl Med. 13(590).","DOI":"10.1126\/scitranslmed.aax5941"},{"issue":"10","key":"11161_CR107","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/stcltm\/szac063","volume":"11","author":"K Khalaj","year":"2022","unstructured":"Khalaj, K., Figueira, R. L., Antounians, L., et al. (2022). Treatment with Amniotic Fluid Stem Cell Extracellular Vesicles Promotes Fetal Lung Branching and Cell Differentiation at Canalicular and Saccular Stages in Experimental Pulmonary Hypoplasia Secondary to Congenital Diaphragmatic Hernia. Stem Cells Transl Med, 11(10), 1089\u20131102.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"11161_CR108","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1164\/rccm.202109-2168OC","volume":"206","author":"K Khalaj","year":"2022","unstructured":"Khalaj, K., Antounians, L., Figueira, R. L., Post, M., & Zani, A. (2022). Autophagy is impaired in fetal hypoplastic lungs and rescued by administration of amniotic fluid stem cell extracellular vesicles. American Journal of Respiratory and Critical Care Medicine, 206(4), 476\u2013487.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"11161_CR109","doi-asserted-by":"publisher","first-page":"350","DOI":"10.20517\/evcna.2025.25","volume":"6","author":"I Atukorala","year":"2025","unstructured":"Atukorala, I., & Hui, L. (2025). A new hope for pulmonary hypoplasia: Amniotic fluid stem cell extracellular vesicles. Extracell Vesicles Circ Nucl Acids, 6(3), 350\u2013354.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"30","key":"11161_CR110","doi-asserted-by":"publisher","first-page":"eadn5405","DOI":"10.1126\/sciadv.adn5405","volume":"10","author":"L Antounians","year":"2024","unstructured":"Antounians, L., Figueira, R. L., Kukreja, B., et al. (2024). Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment. Science Advances, 10(30), eadn5405.","journal-title":"Science Advances"},{"key":"11161_CR111","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jconrel.2024.11.043","volume":"377","author":"F Doktor","year":"2025","unstructured":"Doktor, F., Figueira, R. L., Fortuna, V., et al. (2025). Amniotic fluid stem cell extracellular vesicles promote lung development via TGF-beta modulation in a fetal rat model of oligohydramnios. Journal Of Controlled Release : Official Journal Of The Controlled Release Society, 377, 427\u2013441.","journal-title":"Journal Of Controlled Release : Official Journal Of The Controlled Release Society"},{"issue":"1","key":"11161_CR112","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13287-019-1484-6","volume":"10","author":"G Qiu","year":"2019","unstructured":"Qiu, G., Zheng, G., Ge, M., et al. (2019). Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Research & Therapy, 10(1), 359.","journal-title":"Stem Cell Research & Therapy"},{"issue":"5","key":"11161_CR113","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000515277","volume":"48","author":"AV Chalphin","year":"2021","unstructured":"Chalphin, A. V., Lazow, S. P., Labuz, D. F., et al. (2021). Transamniotic Stem Cell Therapy for Experimental Congenital Diaphragmatic Hernia: Structural, Transcriptional, and Cell Kinetics Analyses in the Nitrofen Model. Fetal Diagnosis And Therapy, 48(5), 381\u2013391.","journal-title":"Fetal Diagnosis And Therapy"},{"issue":"1","key":"11161_CR114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00383-018-4376-4","volume":"35","author":"A Tzanetakis","year":"2019","unstructured":"Tzanetakis, A., Antounians, L., Belfiore, A., et al. (2019). Endoplasmic reticulum stress response is activated in pulmonary hypoplasia secondary to congenital diaphragmatic hernia, but is decreased by administration of amniotic fluid stem cells. Pediatric Surgery International, 35(1), 63\u201369.","journal-title":"Pediatric Surgery International"},{"key":"11161_CR115","doi-asserted-by":"crossref","unstructured":"Doktor, F., Antounians, L., Figueira, R. L., Khalaj, K., Duci, M., & Zani, A. (2025). Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential. Stem Cells Transl Med. 14(1).","DOI":"10.1093\/stcltm\/szae095"},{"issue":"3\u20134","key":"11161_CR116","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/PRM-170449","volume":"10","author":"DO Fauza","year":"2017","unstructured":"Fauza, D. O. (2017). Regenerative medicine and spina bifida: Recent developments in induced fetal regeneration. Journal Of Pediatric Rehabilitation Medicine, 10(3\u20134), 185\u2013188.","journal-title":"Journal Of Pediatric Rehabilitation Medicine"},{"issue":"1","key":"11161_CR117","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpedsurg.2014.10.004","volume":"50","author":"B Dionigi","year":"2015","unstructured":"Dionigi, B., Ahmed, A., Brazzo, J., Connors, J. P., Zurakowski, D., & Fauza, D. O. (2015). Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells. Journal Of Pediatric Surgery, 50(1), 69\u201373.","journal-title":"Journal Of Pediatric Surgery"},{"issue":"6","key":"11161_CR118","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jpedsurg.2016.02.071","volume":"51","author":"C Feng","year":"2016","unstructured":"Feng, C., Graham, C. D., Connors, J. P., Brazzo, J., Zurakowski, D., & Fauza, D. O. (2016). A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida. Journal Of Pediatric Surgery, 51(6), 1010\u20131013.","journal-title":"Journal Of Pediatric Surgery"},{"issue":"11","key":"11161_CR119","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/sctm.19-0002","volume":"8","author":"Y Abe","year":"2019","unstructured":"Abe, Y., Ochiai, D., Masuda, H., et al. (2019). In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion. Stem Cells Transl Med, 8(11), 1170\u20131179.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"11161_CR120","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jpedsurg.2021.02.036","volume":"56","author":"SP Lazow","year":"2021","unstructured":"Lazow, S. P., Labuz, D. F., Kycia, I., Zurakowski, D., & Fauza, D. O. (2021). Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene. Journal Of Pediatric Surgery, 56(6), 1226\u20131232.","journal-title":"Journal Of Pediatric Surgery"},{"issue":"4","key":"11161_CR121","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.retram.2020.04.004","volume":"68","author":"A Dugas","year":"2020","unstructured":"Dugas, A., Larghero, J., Z\u00e9rah, M., Jouannic, J. M., & Guilbaud, L. (2020). Cell therapy for prenatal repair of myelomeningocele: A systematic review. Current Research In Translational Medicine, 68(4), 183\u2013189.","journal-title":"Current Research In Translational Medicine"},{"issue":"3","key":"11161_CR122","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/pd.5887","volume":"41","author":"Y Kunpalin","year":"2021","unstructured":"Kunpalin, Y., Subramaniam, S., Perin, S., et al. (2021). Preclinical stem cell therapy in fetuses with myelomeningocele: A systematic review and meta-analysis. Prenatal Diagnosis, 41(3), 283\u2013300.","journal-title":"Prenatal Diagnosis"},{"issue":"15\u201316","key":"11161_CR123","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1089\/scd.2023.0040","volume":"32","author":"AE Whitlock","year":"2023","unstructured":"Whitlock, A. E., Moskowitzova, K., Kycia, I., Zurakowski, D., & Fauza, D. O. (2023). Morphometric, developmental, and anti-inflammatory effects of transamniotic stem cell therapy (TRASCET) on the fetal heart and lungs in a model of intrauterine growth restriction. Stem Cells And Development, 32(15\u201316), 484\u2013490.","journal-title":"Stem Cells And Development"},{"issue":"15\u201316","key":"11161_CR124","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/scd.2023.0282","volume":"33","author":"AE Whitlock","year":"2024","unstructured":"Whitlock, A. E., Moskowitzova, K., Kycia, I., Zurakowski, D., & Fauza, D. O. (2024). Transamniotic Stem Cell Therapy Modulates Uterine Natural Killer Cell Activity in the Hypoxia Model of Intrauterine Growth Restriction. Stem Cells And Development, 33(15\u201316), 412\u2013418.","journal-title":"Stem Cells And Development"},{"issue":"1","key":"11161_CR125","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jpedsurg.2022.09.018","volume":"58","author":"AE Whitlock","year":"2023","unstructured":"Whitlock, A. E., Moskowitzova, K., Labuz, D. F., Kycia, I., Zurakowski, D., & Fauza, D. O. (2023). Brain protection by transamniotic stem cell therapy (TRASCET) in a model of intrauterine growth restriction (IUGR). Journal Of Pediatric Surgery, 58(1), 3\u20137.","journal-title":"Journal Of Pediatric Surgery"},{"issue":"2","key":"11161_CR126","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jpedsurg.2022.10.021","volume":"58","author":"AE Whitlock","year":"2023","unstructured":"Whitlock, A. E., Moskowitzova, K., Kycia, I., Zurakowski, D., & Fauza, D. O. (2023). Transamniotic stem cell therapy (TRASCET) for intrauterine growth restriction (IUGR): A comparison between placental and amniotic fluid donor mesenchymal stem cells. Journal Of Pediatric Surgery, 58(2), 305\u2013309.","journal-title":"Journal Of Pediatric Surgery"},{"issue":"1","key":"11161_CR127","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1038\/s41598-021-88559-z","volume":"11","author":"SW Shaw","year":"2021","unstructured":"Shaw, S. W., Peng, S., Liang, C., et al. (2021). Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice. Scientific Reports, 11(1), 9158.","journal-title":"Scientific Reports"},{"issue":"2","key":"11161_CR128","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/GCO.0000000000000444","volume":"30","author":"S Peng","year":"2018","unstructured":"Peng, S., & Shaw, S. S. (2018). Prenatal transplantation of human amniotic fluid stem cells for spinal muscular atrophy. Current Opinion In Obstetrics And Gynecology, 30(2), 111\u2013115.","journal-title":"Current Opinion In Obstetrics And Gynecology"},{"issue":"2","key":"11161_CR129","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/scd.2020.0181","volume":"30","author":"S Tai-MacArthur","year":"2021","unstructured":"Tai-MacArthur, S., Lombardi, G., & Shangaris, P. (2021). The Theoretical Basis of In Utero Hematopoietic Stem Cell Transplantation and Its Use in the Treatment of Blood Disorders. Stem Cells And Development, 30(2), 49\u201358.","journal-title":"Stem Cells And Development"},{"issue":"1","key":"11161_CR130","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/stem.1839","volume":"33","author":"SWS Shaw","year":"2015","unstructured":"Shaw, S. W. S., Blundell, M. P., Pipino, C., et al. (2015). Sheep CD34\u2009+\u2009amniotic fluid cells have hematopoietic potential and engraft after autologous in utero transplantation. Stem Cells, 33(1), 122\u2013132.","journal-title":"Stem Cells"},{"issue":"3","key":"11161_CR131","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3727\/096368916X691006","volume":"25","author":"SWS Shaw","year":"2016","unstructured":"Shaw, S. W. S., Bollini, S., Nader, K. A., et al. (2016). Autologous Transplantation of Amniotic Fluid-Derived Mesenchymal Stem Cells into Sheep Fetuses. Cell Transplantation, 25(3), 615.","journal-title":"Cell Transplantation"},{"issue":"9","key":"11161_CR132","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/stem.3039","volume":"37","author":"SP Loukogeorgakis","year":"2019","unstructured":"Loukogeorgakis, S. P., Shangaris, P., Bertin, E., et al. (2019). In utero transplantation of expanded autologous amniotic fluid stem cells results in long-term hematopoietic engraftment. Stem Cells (Dayton, Ohio), 37(9), 1176\u20131188.","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"8","key":"11161_CR133","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/scd.2017.0116","volume":"27","author":"P Shangaris","year":"2018","unstructured":"Shangaris, P., Loukogeorgakis, S. P., Blundell, M. P., et al. (2018). Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice. Stem Cells And Development, 27(8), 515\u2013523.","journal-title":"Stem Cells And Development"},{"key":"11161_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1564964","volume":"13","author":"K Thetchinamoorthy","year":"2025","unstructured":"Thetchinamoorthy, K., Jarczak, J., Kieszek, P., et al. (2025). Very small embryonic-like stem cells (VSELs) on the way for potential applications in regenerative medicine. Frontiers In Bioengineering And Biotechnology, 13, Article 1564964.","journal-title":"Frontiers In Bioengineering And Biotechnology"},{"issue":"4","key":"11161_CR135","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s12015-026-11078-9","volume":"22","author":"B Deepa","year":"2026","unstructured":"Deepa, B. (2026). Relationship Between VSELs, MUSE Cells and MSCs in Health and Disease. Stem Cell Rev Rep, 22(4), 2050\u20132060.","journal-title":"Stem Cell Rev Rep"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11161-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:02:20Z","timestamp":1783674140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11161"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11161-1","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}